Utilization_of_bone_scans_in_conjunction_with_prostate-specific_antigen_levels_in_the_surveillance_for_recurrence_of_adenocarcinoma_after_radical_prostatectomy._Follow-up_evaluation_of_patients_who_have_undergone_radical_prostatectomy_routinely_consists_of_serial_bone_scintigraphy_and,_more_recently,_prostate-specific_antigen_(PSA)_levels._The_utility_of_serial_bone_scans_in_combination_with_PSA_levels_is_retrospectively_reviewed_in_118_men_treated_by_radical_prostatectomy_for_clinical_Stage_A_or_B_disease_who,_at_the_time_of_surgery,_had_no_evidence_of_metastatic_disease._Of_the_118_patients,_75.4%_had_no_abnormality_on_either_test_(mean_follow-up_32.4_mo),_9.3%_demonstrated_a_detectable_or_rising_PSA_level_with_negative_bone_scan_(mean_follow-up_35_mo),_and_8.5%_exhibited_a_detectable_and_or_rising_PSA_level_and_positive_bone_scan_(mean_follow-up_30.7_mo)._Follow-up_bone_scans_were_read_as_either_positive_or_indeterminate_with_undetectable_PSA_levels_in_6.8%_of_patients_(mean_follow-up_27.3_mo)._Critical_review_of_the_equivocal_studies_suggests_that_postoperative_PSA_levels_more_truly_represent_the_clinical_situation_than_bone_scans._Following_radical_prostatectomy,_routine_bone_scintigraphy_provides_little_additional_information_when_PSA_levels_are_negative._If_PSA_becomes_detectable_or_the_patient_develops_symptoms,_bone_scintigraphy_should_then_be_performed.